glp 1 allergy A Closer Look at the Dermatological Profile of GLP-1 Agonists GLP-1 Agonist Allergic Reactions: Symptoms,
Description
Weiss, T
S2CID 33327108
Elective procedures: if daily dosing, DC on the day of surgery
The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]
Recent research from Oxford confirms that patients who combine GLP-1 medications with lasting lifestyle changes have the best long-term outcomes
doi: 10.1007/s00125-016-3938-z
